NETTER-3
Novartis
Novartis
Orano Med LLC
Amgen
RayzeBio, Inc.
ITM Solucin GmbH
Turning Point Therapeutics, Inc.
RayzeBio, Inc.
Boston Scientific Corporation
Legend Biotech USA Inc
Exelixis
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Hoffmann-La Roche
Eisai Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Advanced Accelerator Applications
Chimeric Therapeutics
SAPU NANO (US) LLC
Guerbet
Advanced Accelerator Applications
TaiRx, Inc.
ITM Solucin GmbH
Tanabe Pharma America, Inc.
Perspective Therapeutics
Debiopharm International SA
Camurus AB
BioXcel Therapeutics Inc
Novelty Nobility, Inc.
Merck Sharp & Dohme LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Hutchmed
Circle Pharma
ITM Solucin GmbH
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Sinotau Pharmaceutical Group
Ariceum Therapeutics GmbH
Hutchmed
PharmaMar
Nuvation Bio Inc.
Orano Med LLC
Jiangsu HengRui Medicine Co., Ltd.
Hoffmann-La Roche
Hutchmed
Harbour BioMed (Guangzhou) Co. Ltd.
Ascentage Pharma Group Inc.
EpicentRx, Inc.
Sichuan Huiyang Life Science and Technology Corporation
Clarity Pharmaceuticals Ltd
Novartis